for Jan 03, 2023 through Jan 09, 2023
🔥🔥NEW 🔥🔥
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 4, 2023
Our new post, a great collaboration w 🌟 @IDstewardship
Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature
1️⃣7️⃣⚡️🆔 RCTs @NEJM @TheLancet ✨
2️⃣syst Rev
3️⃣🌏Guidelines @Wiki_Guidelines
#IDTwitter #TwitteRxhttps://t.co/JL07NLa3BV pic.twitter.com/Qcf2cwK8Sd
A.🆕️⚡️systematic review and meta-analysis
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 5, 2023
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by ESBL-producing Enterobacteriaceae
One RCT and 25 cohorts involving 2786 patients #IDTwitter https://t.co/rLzDvmKiq5
New today in @ICHEJournal from @IDstewardship et al
— Infection Control & Hospital Epidemiology (@ICHEJournal) January 4, 2023
The infectious diseases pharmacist: An essential partner for health-system leadership in keeping pace with the coronavirus disease 2019 (COVID-19) pandemic
📄: https://t.co/PlWTJh6pvm pic.twitter.com/24DV1xla0r
Stewardship means the right antibiotic for the right patient at the right time, not just less antibiotics.
— Zain Chagla (@zchagla) January 9, 2023
With algorithms and a limited selection, this isn’t going to make things worse -it’s appropriate use.
Inappropriate use fuels resistance https://t.co/7BgOiYUQYr
Best Infectious Diseases Articles From 2022 - A Year End Review Of Non-COVID Literature - https://t.co/3ls89HeGeb @IDstewardship @ABsteward
— Cansu Cimen (@CimenCansu) January 5, 2023
🆕️⚡️⚡️ @OFIDJournal @thefunguskidd @AlirezaAbdolra1
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 7, 2023
Fungal Nomenclature: Managing Change is the Name of the Game
Candida glabrata >>>Nakaseomyces glabrataa
Candida krusei >>>Pichia kudriavzevii😤#IDTwitter https://t.co/KZKzIUEdHz pic.twitter.com/aGqlBEwfvq
Canada detects poliovirus in wastewater samples
— CIDRAP (@CIDRAP) January 5, 2023
The CDC is testing the Canadian samples to see if they are genetically related to poliovirus samples from New Yorkhttps://t.co/cVdVq5nNKP#polio
Just in time!
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 6, 2023
🌟Fantastic Review Article🌟 @antibioticsmdpi
Antimicrobial Treatment of Staphylococcus aureus Biofilms #MustRead #IDTwitter https://t.co/6mBTIuUjAS pic.twitter.com/4zL32z5W0k
ICMR followed a systematic approach to establish a framework for implementation of antimicrobial stewardship in Indian hospitals which led to improvement in various antimicrobial stewardship implementation indicators. It has been published @WHOBulletin. https://t.co/f7XYhUnoRy pic.twitter.com/dk605FuBES
— ICMR (@ICMRDELHI) January 5, 2023
About that @AnnalsofIM RCT comparing N95s to surgical masks in healthcare workers ... I read the study, the editorial, and several smart commentaries.
— Paul Sax (@PaulSaxMD) January 5, 2023
Great study! We need more like this!
But not (for now) going to change what I do. Here's why:https://t.co/9Wa2OLBEVe
Study of microbes that give cheeses flavor
— MicrobesInfect (@MicrobesInfect) January 7, 2023
Pseudoalteromonas (marine bacteria found in various cheeses) produced the greatest number of flavor compounds. The microbes produced esters, ketones & sulfur compounds, which impart fruity, moldy & oniony flavorshttps://t.co/e3fjFhkyYN
Our experience of establishing a framework for implementing antimicrobial stewardship in Indian tertiary care hospitals is now published @ICMRDELHI@WHOBulletin #AMR #antimicrobialstewardshiphttps://t.co/9rjvin45Ri pic.twitter.com/bP8pYVtkbz
— 🇮🇳 Kamini Walia PhD, MPH (@KaminiWalia) January 4, 2023
🆕️⚡️⚡️Narrative Review @InfectDis_Ther @johnsontannerm
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 7, 2023
Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections(NTM)
Non-stop ID learning process, Follow @ABsteward
A shameless self-promotion #IDTwitter https://t.co/HOTmnmDVtD pic.twitter.com/YPnChIlLe8
🆕️⚡️⚡️ Cross sectional study @jamanetworkopen
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 4, 2023
32 100 patients with BSI
183 US hospitals
Receipt of appropriate empirical antimicrobial therapy was associated with lower in-hospital mortality for pts infected w GN rods, gram-positive cocci & Candida sphttps://t.co/uF7ocDSUKy pic.twitter.com/QJt8mmFCAZ
🆕️⚡️ @antibioticsmdpi
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 6, 2023
Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of CDI
Despite higher fidaxomicin drug costs, overall cost savings were estimated at GBP 140,292 (GBP 2125 per CDI #IDTwitter https://t.co/QKnKXRAYil pic.twitter.com/pn0FSR4Z0h
"Antibiotic residues found in wastewater and wastewater treatment plants... [create] potential hotspots for the development of antibiotic resistance, which creates human health risks from environmental exposure via drinking water." https://t.co/SEi8k1brsi
— Stop Superbugs (@TheUrgentNeed) January 5, 2023
Clostridium innocuum has been implicated as a potential causative agent of diarrhea in patients from whom Clostridioides difficile could not be isolated. This #mSphere study is the first to explore the bacterium's diversity & prevalence in the human gut: https://t.co/1MFd6aXtzr pic.twitter.com/sykP6b0iR1
— ASM (@ASMicrobiology) January 9, 2023
🔥Ohh Finally @DrToddLee 🔥
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 7, 2023
With the 🌟 @DrEmilyMcD
🆕️⚡️ @jac_amr @davidvanduin
Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada? #IDTwitter https://t.co/JdHC4TnAy7 pic.twitter.com/zdd5g2EnJL
Twitter's new owner, Elon Musk, announced that the next installment of the "Twitter Files" about the former head of the National Institute for Allergy and Infectious Diseases, Dr. Anthony Fauci, who retired Saturday, will be released "later this week."https://t.co/KQCltYx2WX
— Ken Winsor (@KenWinsor4) January 3, 2023
The other point is that COVID looks special a lot of the time because we don't bother to examine other infectious diseases in this level of detail- but you can even see changes in monocyte behavior with influenza vaccination, as the paper points out: https://t.co/1t2p3UsFkk
— Edward Nirenberg 🇺🇦 (@ENirenberg) January 3, 2023
A New Weapon Against Antibiotic-Resistant Bacteria.@UNIGEnews researchers found that #edoxudine, an anti-herpes drug developed in 1960s, can disrupt protective surface of #Klebsiella bacteria & make them more vulnerable to elimination by immune cellshttps://t.co/fpANVipslx
— MicrobesInfect (@MicrobesInfect) January 8, 2023
Revive Therapeutics Announces Publication Showing Bucillamine’s Potential Impact on COVID-19 Omicron Variants
— Revive Therapeutics (CSE: RVV, US: RVVTF) Official (@Revive_RVV) January 9, 2023
Learn more: https://t.co/VCf085wwPI $RVV $RVVTF #Bucillamine #Infectiousdiseases #Covid19 #FDA pic.twitter.com/47w9388lVL
Report estimates deaths, costs from #Cdiff, #MRSA infections in Canada
— CIDRAP (@CIDRAP) January 3, 2023
Infections caused by C difficile and MRSA resulted in 1,743 premature deaths in Canada in 2019 and cost hospitals more than $91 million (USD)https://t.co/7RXB6fMREC#AMR #AntibioticStewardship @CIDRAP_ASP
New correspondence: Stability of hybrid versus vaccine immunity against BA.5 infection over 8 monthshttps://t.co/CdgJgfqgXd pic.twitter.com/JM27oAyffK
— The Lancet Infectious Diseases (@TheLancetInfDis) January 6, 2023
A surge in bacterial infections after countries lifted #COVID19 restrictions led to shortages of #antibiotic drugs like penicillin and amoxicillin, highlighting the precarious state of global supply chains, @FT reports. @hannahkuchler https://t.co/y6JRSXPeXi
— Save Antibiotics (@saveantibiotics) January 3, 2023
In aquatic environments, bacteria w/ cell sizes of ~0.1 μm are an important part of the microbial community & can show metabolic dependencies w/ other bacteria. Is the same true in soil? Yes, according to this #mSystems study. https://t.co/tbMs5JpCc2 pic.twitter.com/pJlIwSWtEh
— ASM (@ASMicrobiology) January 6, 2023
This study shows that hybrid immunity following infection with Omicron BA.1 or BA.2 when compared with vaccine-only immunity leads to substantially increased protection against BA.5 reinfection for up to 8 months. https://t.co/btSLYAOVdH
— Peter Collignon (@CollignonPeter) January 7, 2023
🆕️⚡️⚡️#JAC by Dr.Hill
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 6, 2023
Evaluation of publication bias for 12 clinical trials of molnupiravir in
13 694 COVID-19 patients with meta-analysis
Based on all available data, molnupiravir does not have a significant effect on hospitalizations
ALT 👇 #IDTwitter https://t.co/xhD5B5eFEb pic.twitter.com/YUvV1qyncg
Check out our systematic review and meta-analysis of urine culture clinical decision support presented @IDWeek2022, now published in @OFIDJournal! https://t.co/J4gAZjvVEL#antimicrobialstewardship #IDTwitter #MedTwitter @abhishek_dp @ElieSaade_MDMPH @ClaeysKcclaeys @Sonali_Advani https://t.co/FKbrbDpwHJ
— Leila Hojat (@LeilaSHojat) January 3, 2023
Test your knowledge on the new fungal names. Look no further. Read this: Fungal Nomenclature: Managing Change is the Name of the Game | Open Forum Infectious Diseases | Oxford Academic https://t.co/eMnt3xi09U
— Mycology Reference Centre Manchester (@MycologyRefManc) January 8, 2023
#Vectors are living organisms that can transmit #infectious pathogens (parasites, viruses, bacteria) between humans, or from animals to humans. Examples of vectors include, fleas, ticks, mosquitoes, and lice. Learn more here: https://t.co/XUdZw45AGg#OneHealthAwarenessMonth pic.twitter.com/J8xzpBzIEp
— APHA One Health (@APHA_OneHealth) January 4, 2023
Great article on "Rethinking Carbapenems" for necrotizing pancreatitis. https://t.co/StkLE6ost8
— Michael Calderwood, MD, MPH (@CalderwoodMD) January 8, 2023
The protozoan parasite, Crtyptosporidium, is a leading cause of diarrheal disease in young children. In this @JournalSpectrum study, researchers identified tyrosine kinase inhibitors that could serve as new drug candidates against cryptosporidiosis. https://t.co/HgxTIpqHAt pic.twitter.com/7Qn8lIiZcr
— ASM (@ASMicrobiology) January 3, 2023
🫣🫣🫣🫣🫣🫣😲
— Bug Pharmacist 💊🧫 Tim Gauthier (@IDstewardship) January 5, 2023
Does this scare you? It sure scares me. #Acinetobacter #SaveABX #Stewardmeme
Shout out to the @IDSAInfo MDR GNR guidelines which I have found very helpful in recent years. 🙏Thank you!!https://t.co/4xcFXgCBhk pic.twitter.com/t7vKjANqii
Fact: People are dying from common, previously treatable infections because the bacteria that cause them have become resistant available #antibiotics. https://t.co/BpxyMSYr27
— Save Antibiotics (@saveantibiotics) January 3, 2023
Since 2023, I’m honored to serve as Associate Editor of my longtime ID reference @JIDJournal, under the leadership of Editor-in-Chief Cynthia L. Sears and an amazing Ed board.
— Roger Paredes (@RutgerWalls) January 6, 2023
Editorial_Board | The Journal of Infectious Diseases | Oxford Academic https://t.co/stpuBlyjHC
Study finds that people with higher levels of the gut bacteria Coprococcus tended to have higher insulin sensitivity, while those whose #microbiome had higher levels of the bacterium Flavonifractor tended to have lower #insulin sensitivityhttps://t.co/FWdqRM8boR #diabetes
— MicrobesInfect (@MicrobesInfect) January 6, 2023
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
— Revive Therapeutics (CSE: RVV, US: RVVTF) Official (@Revive_RVV) January 5, 2023
Learn more: https://t.co/tHLj0tfkUp $RVV $RVVTF #Bucillamine #Infectiousdiseases #Covid19 #FDA pic.twitter.com/2kCTIUXdFn
#MicrobiologyMonday: Scientists show that many skin bacteria prefer high sweat concentrations while preferences for sebum levels are variable, indicating it may help regulate skin microbiota composition in regions across the body. @JournalSpectrum: https://t.co/T9d9fMxdsh pic.twitter.com/XwgYUHS8zC
— ASM (@ASMicrobiology) January 9, 2023
New blood test to identify infections could reduce global antibiotic overuse.
— MicrobesInfect (@MicrobesInfect) January 4, 2023
A diagnostic test developed by @StanfordMed can separate bacterial & viral infections with 90% accuracy.https://t.co/77QJW4T0bA
🆕️The bacterial protein BlaR1 regulates resistance to β-lactam antibiotics in the MDR bacteria, Staphylococcus aureus. Cryo-electron microscopy has revealed the detailed structures of BlaR1 in its resting state and in its β-lactam-bound activated state.https://t.co/5CqIJnfi33 pic.twitter.com/EJzDGQEkuB
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 5, 2023
#PublicHealth Professionals: CDC’s National Notifiable Diseases Surveillance System released a new interactive data tool on WONDER. Users can customize visualizations and compare infectious disease data across years, populations, and locations. Learn more: https://t.co/mYJJA9OaFX pic.twitter.com/XZ66fpzXyi
— CDC (@CDCgov) January 6, 2023
Specialists in infectious diseases and global health that CBC News spoke to said the move will do little to prevent the virus from coming to Canada in increased numbers. https://t.co/Hu4aa4QFNo
— CBC News (@CBCNews) January 3, 2023
Since its discovery in 1928,
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 7, 2023
C. parapsilosis has undergone several changes in phylogenetic classification
🆕️⚡️Review in #JOF
Candida parapsilosis Virulence and Antifungal Resistance Mechanisms: A Comprehensive Review of Key Determinants #IDTwitter https://t.co/pAFjyQsCcI pic.twitter.com/JowsrOw2eH
Not so Emmanuel. GRAM study (https://t.co/Nqx8Xh453U )shows 4.95 million people died on 2019 with an antimicrobial resistant infection, with 1.27 million dying as a direct result of resistance https://t.co/uLnj3oyFvX
— Marc Mendelson (@SouthAfricanASP) January 8, 2023
Study finds 'major reservoir' of resistance in wastewater of Southeast Asia. The potential of the residues to mix with bacteria/resistance genes & promote the emergence of resistant pathogens could pose potential human health risk #AMR @CIDRAP_ASP https://t.co/1wv66lVX6w
— Lauren Hunt (@LNHsteward) January 7, 2023
🔥 Multinational consensus antimicrobial stewardship recommendations for children in hospital settings. Great leadership. @brendanmcID https://t.co/dr7l7kDMPo
— NCAS_Australia (@NCAS_Aus) January 9, 2023
Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing - PubMed https://t.co/UFm6NKwOyx
— Laura Piddock 💙 (@LauraPiddock) January 9, 2023
Congrats to former resident Erin Warren & current @PHUofSCPharmRes PGY1 @JakeCrocker3 on leading work on a neat case series on successful use of combo nafcillin PLUS ceftaroline in persistent MSSA bacteremia & IE.
— P. Brandon Bookstaver (@BBookstaver_USC) January 5, 2023
Published in @jac_amr https://t.co/XNTGWGPSjG
#Antibiotic stewardship programs in nursing homes decrease #antibiotic use and multidrug-resistant organisms without causing an increase in hospitalizations due to infection, new research in @CIDJournal shows. https://t.co/wzmRMxos4B
— Save Antibiotics (@saveantibiotics) January 4, 2023
Super interesting⚡️⚡️
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 4, 2023
Going Back in Time: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children @DrToddLee @syctong @Josh_S_Davis #IDTwitter https://t.co/SjVqi9javW
Created by Cameron Forbes. Last updated January 31, 2023 at 05:16 EST.